SteadMed® Medical, LLC, a healthcare company providing medical devices and products to hospitals, wound care centers, nursing homes and home health agencies, announces that four of its poster abstracts were accepted for review at the Symposium for Advanced Wound Care held April 14-16 in Grapevine, Texas. One abstract, titled "Drawtex®: The Effect of Accelerated Exudate Removal on the Bioburden of Venous Leg Ulcers," won first place.
The poster, authored by Randall Wolcott, MD, of the Southwest Regional Wound Care Center and Scot Dowd, PhD, was the highest scoring abstract in the clinical research category. The competition was judged by the North American Center for Continuing Medical Education, LLC (NACCME).
"Close to 300 abstracts were accepted as posters for the SAWC based on a blind, peer-review by judges who are experts in the field," explains Tiffney D. Oliver, director of educational services for NACCME. "Of those, 52 were designated as clinical research. All abstracts were reviewed based on specific criteria for the category in which they were placed."
The three other poster abstracts accepted for review were:
- Detoxification of Venous Ulcers with a Novel Hydroconductive Wound Dressing That Transfers Chronic Wound Fluid Away From the Wound Phillip Lichtenstein, Martin Wendelken, DPM, RN and Oscar M. Alvarez, PhD
- Hydroconductive Debridement: A New Perspective in Reducing Slough and Necrotic Tissue Matthew W. Livingston, RN, BSN, CWS, ACHRN and Tom A. Wolvos, MS, MD, FACS
- Clinical Practice Evaluation and Usage of a Novel Absorbent Dressing Dot Weir, RN, CWON, CWS and Melodie Blakely, PT, MS, CWS
SteadMed® Medical is the sole distributor of Drawtex® in the United States and Canada. Michael Steadman, CEO, commented on the award: "It is such an honor to win a blue ribbon at the SAWC, as this is our first year to participate. We are thrilled to be recognized by wound care experts at one of the largest conferences for these clinicians in the United States."
In addition to its poster series, SteadMed® Medical displayed four of its featured products at the show, including Elta® SilverGel, Elta® Crème, the Protease Technology Incontinence line and Drawtex®, a hydroconductive wound dressing with LevaFiber technology.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.